Log in using OpenID

Recombinant Vaccines Market Key Trends in terms of volume and value 2017-2025

The global recombinant vaccine market was valued at US$ 830.2 million in 2016 and is expected to witness a robust CAGR of 6.0% during the forecast period (2017 – 2025).
Recombinant Vaccines Market Size, Share,
Trend, Outlook, Future Growth Analysis
And Synthesis By 2025
Recombinant vaccines are produced by using recombinant DNA technology or genetic engineering for the
prevention of lethal diseases in human beings and animals. Recombinant vaccine is a biological
preparation that provides active acquired immunity against a certain disease. Whereas individual being
vaccinated produces antibodies against the protein antigen that protect a person from contracting the
disease upon attack from the pathogenic microorganism. These vaccines functions on the immune
response for diseases and to have preventive measures against diseases caused by various bacteria, and
virus. These vaccines are much more advanced and effective as compare to conventional vaccines in the
prevention of diseases such as malaria, typhoid, and human papillomavirus (HPV). Furthermore, Europe
dominates the animal recombinant vaccines market as compared to other regions due to highly
organized livestock and major demand for livestock products in Europe.
Get Free Exclusive PDF Sample Copy of This Report @
Market Dynamics:
The recent past has witnessed a steady rise in incidence of zoonotic and infectious diseases in humans
and animals as well, which lead to the increased research & developments for the innovation of new
and effective recombinant vaccines for the prevention of diseases. Government has also taken an
initiative to increase awareness regarding vaccination to prevent diseases in community. Manufacturing
companies have also started some beneficial programs to provide vaccination free of cost to poor people,
which creates a highly conducive environment for growth of the recombinant vaccines market in near
future. National Immunization Program by Queensland Government in Australia and Indradhanush
vaccination program in India works to provide vaccination among children throughout the nation.
Various organizations such as World Health Organization, World Bank, and United Nations Children’s
Funds has also taken and initiative to increase vaccination.
The global recombinant vaccine market was valued at US$ 830.2 million in 2016 and is expected to
witness a robust CAGR of 6.0% during the forecast period (2017 – 2025).
Increase in the incidence of zoonotic diseases and emerging technologies expected to support the growth
of recombinant vaccines market
There is a constant increase in diseases caused by bacteria or virus such as swine flu, malaria,
HPV and other diseases, which has raised the demand of vaccination and lead to the
eradication of diseases such as polio, and tetanus in few countries. Whit the development in
technology there is development in vaccines, which are more effective than conventional
vaccines and does not lead to any side effect. These vaccines are easy to administer in the body
orally, intramuscular or intradermal. In the U.S. there were around 212 million malaria cases
and 429,000 deaths from malaria is reported in 2015. According to Centers for Disease Control
and Prevention report 2017, in the U.S. there were around 49.9% of the children between the
ages of 6 months to 17 years received an influenza vaccine.
Report includes chapters which deeply display the following deliverable about industry :
• Recombinant Vaccines Market Research Objective and Assumption
• Recombinant Vaccines Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Recombinant Vaccines Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Recombinant Vaccines Market, By Regions
• Recombinant Vaccines Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Recombinant Vaccines Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Recombinant Vaccines Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Recombinant Vaccines Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Top Key Players:
Some major key players in the recombinant vaccines market include Merck & Co. Inc., Novartis AG,
Protein Science Corporation, GlaxoSmithKline Plc., Green Cross Corporation, Bayer AG, Sanofi S A,
Pfizer Inc., and Bharat Biotech.
Detailed Segmentation:
Global Recombinant Vaccines Market, By Product Type •
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Global Recombinant Vaccines Market, By Disease Type •
Infectious Disease
Find the comprehensive research report here with a single click:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Poul Master
Poul Master247   documents Email
Health and Medicine
File Size
120 KB
vaccines, Recombinant Vaccines Market
Report inappropriate content